Rethinking Corticosteroid Therapy in Pediatric Neurology

Area of Science:

• Pediatric Neurology
• Neuroimmunology
• Pharmacology

Background:

• Corticosteroids are a primary treatment for pediatric neurological conditions.
• Concerns exist regarding their broad immunomodulatory effects and potential to exacerbate neuroinflammation in the context of precision medicine.
• Reappraisal of their role is necessary, considering disease-specific immunopathogenesis.

Purpose of the Study:

• To critically re-evaluate the role of corticosteroids in pediatric neurology.
• To explore the potential for corticosteroids to potentiate innate immune responses and neuroinflammation.
• To discuss emerging therapeutic innovations and their safety profiles.

Main Methods:

• Review of existing literature on corticosteroid use in pediatric neurological disorders.
• Analysis of immunomodulatory effects and potential adverse events.
• Examination of novel therapeutic strategies and their clinical evidence.

Main Results:

• Corticosteroids may exacerbate neuroinflammation by potentiating innate immune responses.
• Long-term use necessitates careful risk-benefit analysis due to potential adverse effects.
• Innovations like selective glucocorticoid receptor modulators and novel drug delivery systems show promise.
• Evidence suggests corticosteroid benefit in drug-resistant epilepsies beyond infantile epileptic spasms syndrome.

Conclusions:

• Disease-specific immunopathogenesis should guide therapeutic decisions involving corticosteroids.
• Further research is needed to optimize corticosteroid dosing, formulation, timing, and administration routes for various pediatric neurological disorders.
• Balancing efficacy with safety concerns is paramount in corticosteroid management.